JASVINDER SINGH to Randomized Controlled Trials as Topic
This is a "connection" page, showing publications JASVINDER SINGH has written about Randomized Controlled Trials as Topic.
Connection Strength
2.885
-
A narrative review of the comparative safety of disease-modifying anti-rheumatic drugs used for the treatment of rheumatoid arthritis. Expert Opin Drug Saf. 2024 Jun; 23(6):687-714.
Score: 0.520
-
Do outcomes reported in randomised controlled trials of joint replacement surgery fulfil the OMERACT 2.0 Filter? A review of the 2008 and 2013 literature. Syst Rev. 2017 05 30; 6(1):106.
Score: 0.320
-
Assessment of the methodologic quality of medical and surgical clinical trials in patients with arthroplasty. J Rheumatol. 2009 Dec; 36(12):2642-54.
Score: 0.190
-
Trial sample size, but not trial quality, is associated with positive study outcome. J Clin Epidemiol. 2010 Feb; 63(2):154-62.
Score: 0.187
-
SToRytelliing to Improve Disease outcomes in Gout (STRIDE-GO) in African American veterans with gout: a trial study protocol. Trials. 2021 Dec 04; 22(1):879.
Score: 0.110
-
Belimumab for systemic lupus erythematosus. Cochrane Database Syst Rev. 2021 02 25; 2:CD010668.
Score: 0.104
-
Tai Chi for rheumatoid arthritis. Cochrane Database Syst Rev. 2019 09 25; 9:CD004849.
Score: 0.094
-
Improving Benefit-harm Assessment of Therapies from the Patient Perspective: OMERACT Premeeting Toward Consensus on Core Sets for Randomized Controlled Trials. J Rheumatol. 2019 08; 46(8):1053-1058.
Score: 0.090
-
Biologics or tofacitinib for people with rheumatoid arthritis naive to methotrexate: a systematic review and network meta-analysis. Cochrane Database Syst Rev. 2017 05 08; 5:CD012657.
Score: 0.080
-
Biologics or tofacitinib for rheumatoid arthritis in incomplete responders to methotrexate or other traditional disease-modifying anti-rheumatic drugs: a systematic review and network meta-analysis. Cochrane Database Syst Rev. 2016 May 13; (5):CD012183.
Score: 0.075
-
Risk of serious infection in biological treatment of patients with rheumatoid arthritis: a systematic review and meta-analysis. Lancet. 2015 Jul 18; 386(9990):258-65.
Score: 0.069
-
Chondroitin for osteoarthritis. Cochrane Database Syst Rev. 2015 Jan 28; 1:CD005614.
Score: 0.068
-
Application of the OMERACT filter to measures of core outcome domains in recent clinical studies of acute gout. J Rheumatol. 2014 Mar; 41(3):574-80.
Score: 0.063
-
Use of biologics in rheumatoid arthritis: current and emerging paradigms of care. Clin Ther. 2011 Jun; 33(6):679-707.
Score: 0.053
-
Adverse effects of biologics: a network meta-analysis and Cochrane overview. Cochrane Database Syst Rev. 2011 Feb 16; (2):CD008794.
Score: 0.052
-
Botulinum toxin for shoulder pain: a cochrane systematic review. J Rheumatol. 2011 Mar; 38(3):409-18.
Score: 0.052
-
Tocilizumab for rheumatoid arthritis: a Cochrane systematic review. J Rheumatol. 2011 Jan; 38(1):10-20.
Score: 0.051
-
Surgery for shoulder osteoarthritis. Cochrane Database Syst Rev. 2010 Oct 06; (10):CD008089.
Score: 0.051
-
Botulinum toxin for shoulder pain. Cochrane Database Syst Rev. 2010 Sep 08; (9):CD008271.
Score: 0.050
-
Tocilizumab for rheumatoid arthritis. Cochrane Database Syst Rev. 2010 Jul 07; (7):CD008331.
Score: 0.050
-
Golimumab for rheumatoid arthritis: a systematic review. J Rheumatol. 2010 Jun; 37(6):1096-104.
Score: 0.049
-
Pegloticase for chronic gout. Cochrane Database Syst Rev. 2010 Mar 17; (3):CD008335.
Score: 0.049
-
Golimumab for rheumatoid arthritis. Cochrane Database Syst Rev. 2010 Jan 20; (1):CD008341.
Score: 0.048
-
Abatacept for rheumatoid arthritis: a Cochrane systematic review. J Rheumatol. 2010 Feb; 37(2):234-45.
Score: 0.048
-
Abatacept for rheumatoid arthritis. Cochrane Database Syst Rev. 2009 Oct 07; (4):CD007277.
Score: 0.047
-
Quality of life and quality of care for patients with gout. Curr Rheumatol Rep. 2009 Apr; 11(2):154-60.
Score: 0.046
-
Improved health-related quality of life with effective disease-modifying antirheumatic drugs: evidence from randomized controlled trials. Am J Manag Care. 2008 Apr; 14(4):234-54.
Score: 0.042
-
Improved health-related quality of life with effective disease-modifying antirheumatic drugs: evidence from randomized controlled trials. Am J Manag Care. 2007 Dec; 13 Suppl 9:S237-51.
Score: 0.041
-
Systemic treatments for atopic dermatitis (eczema): Systematic review and network meta-analysis of randomized trials. J Allergy Clin Immunol. 2023 12; 152(6):1470-1492.
Score: 0.031
-
Outcome reporting in randomized trials in gout: A systematic scoping review from the OMERACT gout working group assessing the uptake of the core outcome set. Semin Arthritis Rheum. 2023 06; 60:152191.
Score: 0.030
-
Interpretation of chronic pain clinical trial outcomes: IMMPACT recommended considerations. Pain. 2020 11; 161(11):2446-2461.
Score: 0.025
-
Shoulder replacement surgery for osteoarthritis and rotator cuff tear arthropathy. Cochrane Database Syst Rev. 2020 04 21; 4:CD012879.
Score: 0.024
-
Defining the optimal biological monotherapy in rheumatoid arthritis: A systematic review and meta-analysis of randomised trials. Semin Arthritis Rheum. 2017 06; 46(6):699-708.
Score: 0.019
-
TNF-alpha inhibitors for ankylosing spondylitis. Cochrane Database Syst Rev. 2015 Apr 18; (4):CD005468.
Score: 0.017
-
OARSI/OMERACT initiative to define states of severity and indication for joint replacement in hip and knee osteoarthritis. An OMERACT 10 Special Interest Group. J Rheumatol. 2011 Aug; 38(8):1765-9.
Score: 0.013
-
Biologicals for rheumatoid arthritis. BMJ. 2011 Jul 28; 343:d4027.
Score: 0.013
-
Serum urate in chronic gout--will it be the first validated soluble biomarker in rheumatology? J Rheumatol. 2011 Jul; 38(7):1462-6.
Score: 0.013